These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 2033099)

  • 1. Ascites in a woman with chronic mitral stenosis.
    Litam PP; Smaha LA
    Hosp Pract (Off Ed); 1991 May; 26(5A):35-6, 38. PubMed ID: 2033099
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of carboplatin based combination chemotherapy on ovarian cancer.
    Feng Y; Zhang X; Sun H
    Chin Med J (Engl); 1996 May; 109(5):349-52. PubMed ID: 9208489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of advanced ovarian clear cell adenocarcinoma responding to cisplatin-cyclophosphamide and paclitaxel-carboplatin].
    Iwasaki K; Komuro Y; Masumoto N; Asaoka K; Ishitani K
    Gan To Kagaku Ryoho; 1999 Sep; 26(10):1483-6. PubMed ID: 10500539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carboplatin hypersensitivity presenting as coronary vasospasm - a case report.
    Chasen MR; Ebrahim IO
    Cancer Chemother Pharmacol; 2002 Nov; 50(5):429-31. PubMed ID: 12439602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial ovarian cancer treated by platinum or platinum analogue with cyclophosphamide: experience in Ramathibodi Hospital.
    Linasmita V; Wilailak S; Srisupundit S; Tangtrakul S; Bullangpoti S; Israngura N
    J Med Assoc Thai; 1998 Jan; 81(1):10-6. PubMed ID: 9470316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of neo-JP therapy in the treatment of ovarian carcinoma].
    Matsunami K; Takagi H; Hasegawa Y
    Gan To Kagaku Ryoho; 1995 Jan; 22(1):153-5. PubMed ID: 7826073
    [No Abstract]   [Full Text] [Related]  

  • 7. [A case of ovarian cancer with metastatic tumor in the liver with paclitaxel and carboplatin systemic chemotherapy was very effective].
    Honda T; Ishii T; Kawashima S; Fukasawa H; Iwamoto H; Shimazu Y; Yamanaka T; Shoda T; Kitamura T; Hashi A; Hirata S; Hoshi K
    Gan To Kagaku Ryoho; 2001 Nov; 28(12):1923-7. PubMed ID: 11729489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian carcinosarcomas: clinicopathological prognostic factors and evaluation of chemotherapy regimens containing platinum.
    Cicin I; Saip P; Eralp Y; Selam M; Topuz S; Ozluk Y; Aydin Y; Topuz E
    Gynecol Oncol; 2008 Jan; 108(1):136-40. PubMed ID: 17936342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of ovarian cancer stage IV and advanced rectal cancer responding to paclitaxel/carboplatin].
    Kawaguchi R; Furukawa N; Morimoto Y; Ohi M; Osawa T; Koike H; Miyake T
    Gan To Kagaku Ryoho; 2004 Apr; 31(4):619-22. PubMed ID: 15114712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy for ovarian adult granulosa cell tumour with synchronous endometrial adenocarcinoma.
    Ohara N; Teramoto K; Murao S
    J Obstet Gynaecol; 2002 Sep; 22(5):573-4. PubMed ID: 12521449
    [No Abstract]   [Full Text] [Related]  

  • 11. Hypersensitivity reactions to carboplatin.
    Planner RS; Weerasiri T; Timmins D; Grant P
    J Natl Cancer Inst; 1991 Dec; 83(23):1763-4. PubMed ID: 1770557
    [No Abstract]   [Full Text] [Related]  

  • 12. Combined therapy with Ukrain and chemotherapy in ovarian cancer (case report).
    Lohninger A; Korsh OB; Melnyk A
    Drugs Exp Clin Res; 1996; 22(3-5):259-62. PubMed ID: 8899343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intraperitoneal high dose chemotherapy as consolidation treatment for advanced ovarian carcinoma: a pilot study].
    Gladieff L; Chatelut E; Gaspard MH; Skaf R; de Forni M; Mihura J; Canal P; Bugat R
    Bull Cancer; 1999; 86(7-8):673-7. PubMed ID: 10477384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Taxol in the treatment of ovarian neoplasm].
    Wang Y; Huang R; Huang H
    Zhonghua Fu Chan Ke Za Zhi; 1999 Jul; 34(7):439-41. PubMed ID: 11360659
    [No Abstract]   [Full Text] [Related]  

  • 15. High-dose platinum versus standard dose in advanced ovarian carcinoma: a randomized trial from the Gynecologic Cooperative Group of the French Comprehensive Cancer Centers (FNCLCC).
    Joly F; Héron JF; Kerbrat P; Chauvergne J; Rios M; Mayer F; Chinet-Charrot P; Goupil A; Lebrun-Jezekova D; Vennin D; Lhommé C; Macé-Lesec'h J; Crouet H
    Gynecol Oncol; 2000 Sep; 78(3 Pt 1):361-8. PubMed ID: 10985895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study on hematological effects of carboplatin plus cyclophosphamide and carboplatin plus paclitaxel chemotherapy for the first line treatment of epithelial ovarian cancer.
    Vapattanawong P
    J Med Assoc Thai; 2006 Sep; 89(9):1357-61. PubMed ID: 17100369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute digital ischemia complicating gemcitabine and carboplatin combination chemotherapy for ovarian cancer.
    Staff S; Lagerstedt E; Seppänen J; Mäenpää J
    Acta Obstet Gynecol Scand; 2011 Nov; 90(11):1296-7. PubMed ID: 21880022
    [No Abstract]   [Full Text] [Related]  

  • 18. Possible interactions between antiblastic agents and warfarin inducing prothrombin time abnormalities.
    Malacarne P; Maestri A
    Recenti Prog Med; 1996 Mar; 87(3):135. PubMed ID: 8650435
    [No Abstract]   [Full Text] [Related]  

  • 19. [The effect of carboplatin combined chemotherapy on renal function in patients with ovarian carcinoma].
    Yang Q; Lu J; Kumazawa T
    Zhonghua Fu Chan Ke Za Zhi; 1998 Jun; 33(6):358-60. PubMed ID: 10806676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of therapeutic efficacy between TP regimen and CBP regimen on epithelial ovarian cancer after optimal cytoreductive operation].
    Gao KF; Liu FY; Chen FJ; Feng YL
    Ai Zheng; 2007 Apr; 26(4):431-4. PubMed ID: 17430668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.